Escitalopram or novel herbal mixture treatments during or following exposure to stress reduce anxiety-like behavior through corticosterone and BDNF modifications.
Anxiety disorders are a major public health concern worldwide. Studies indicate that repeated exposure to adverse experiences early in life can lead to anxiety disorders in adulthood. Current treatments for anxiety disorders are characterized by a low success rate and are associated with a wide vari...
Main Authors: | Ravid Doron, Dafna Lotan, Ziv Versano, Layla Benatav, Motty Franko, Shir Armoza, Nadav Kately, Moshe Rehavi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0091455&type=printable |
Similar Items
-
Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression.
by: Or Burstein, et al.
Published: (2017-01-01) -
Assessment of Pharmacokinetic Effects of Herbal Medicines on Escitalopram
by: Jung YS, et al.
Published: (2024-02-01) -
MK-801 changes the expression of mBDNF and proBDNF in the hippocampus of rats with corticosterone-induced depression-like behavior
by: LI Jian-guo, WANG Ying, LI Yue-tian, YAN Zi, ZHAO Xin, ZHANG Yu
Published: (2021-08-01) -
Taurine and Ginsenoside Rf Induce BDNF Expression in SH-SY5Y Cells: A Potential Role of BDNF in Corticosterone-Triggered Cellular Damage
by: Won Jin Lee, et al.
Published: (2020-06-01) -
Escitalopram in patients with psoriasis
by: M. Artemieva, et al.
Published: (2021-04-01)